Ribomic Inc.

TSE:4591 Stock Report

Market Cap: JP¥3.3b

Ribomic Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Yoshikazu Nakamura

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.7yrs
CEO ownership1.4%
Management average tenureno data
Board average tenure5yrs

Recent management updates

Recent updates

Companies Like Ribomic (TSE:4591) Are In A Position To Invest In Growth

Oct 30
Companies Like Ribomic (TSE:4591) Are In A Position To Invest In Growth

We're Not Very Worried About Ribomic's (TSE:4591) Cash Burn Rate

Jul 02
We're Not Very Worried About Ribomic's (TSE:4591) Cash Burn Rate

CEO

Yoshikazu Nakamura (77 yo)

12.7yrs

Tenure

Mr. Yoshikazu Nakamura, Ph.D. has been the President at Ribomic Inc. since April 2012 and has been its Chief Executive Officer since 2012. Mr. Nakamura has been a Representative Director at Ribomic Inc. Oc...

Board Members

NamePositionTenureCompensationOwnership
Yoshikazu Nakamura
CEO, President & Representative Director19.2yrsno data1.4%
¥ 46.0m
Hisato Oiwa
Executive Officerno datano datano data
Toshiaki Nishihata
Independent Outside Director8.5yrsno datano data
Yutaka Yabe
Outside Auditor14.5yrsno datano data
Robert B. Bhisitkul
Member of Scientific Advisory Boardno datano datano data
Yasuhiro Fujii
Independent Outside Auditor6.5yrsno datano data
Pavel Krejcí
Member of Scientific Advisory Boardno datano datano data
Masatsugu Nakamura
Member of Scientific Advisory Boardless than a yearno datano data
Senya Matsufuji
Independent Outside Director3.5yrsno data0.098%
¥ 3.2m
Toshinobu Fujiwara
Independent Outside Director1.5yrsno datano data
Akiyuki Igarashi
Independent Auditor1.5yrsno datano data

5.0yrs

Average Tenure

67yo

Average Age

Experienced Board: 4591's board of directors are considered experienced (5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 00:32
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ribomic Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kazuaki HashiguchiDaiwa Securities Co. Ltd.
Kiyokazu YamazakiIchiyoshi Research Institute Inc.